Milestone Pharmaceuticals Inc
NASDAQ:MIST
Milestone Pharmaceuticals Inc
NASDAQ:MIST
Price:
2.2
USD
8.37%
Market Cap:
$258.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Milestone Pharmaceuticals Inc
NASDAQ:MIST
|
CA |
|
Cantor Equity Partners Inc
NASDAQ:CEP
|
US |
|
Ventas Inc
NYSE:VTR
|
US |
|
N
|
Norsk Hydro ASA
DUS:NOH1
|
NO |
|
G
|
Glencore PLC
JSE:GLN
|
CH |
|
A
|
Ambra SA
WSE:AMB
|
PL |
|
Mapletree Pan Asia Commercial Trust
SGX:N2IU
|
SG |
|
Flight Holdings Inc
TSE:3753
|
JP |
|
Mgi Digital Technology SA
OTC:FRIIF
|
FR |
|
Zodiac Clothing Company Ltd
NSE:ZODIACLOTH
|
IN |
|
P
|
Prudential Financial Inc
BMV:PRU
|
US |
|
R
|
Red Metal Ltd
ASX:RDM
|
AU |
|
R
|
Ruentex Engineering & Construction Co Ltd
TWSE:2597
|
TW |
|
PGG Wrightson Ltd
NZX:PGW
|
NZ |
|
M
|
Matrix Composites & Engineering Ltd
ASX:MCE
|
AU |
|
Healthier Choices Management Corp
OTC:HCMC
|
US |
|
K
|
Kafrit Industries 1993 Ltd
TASE:KAFR
|
IL |
|
P
|
Promimic AB
STO:PRO
|
SE |
|
Royal Helium Ltd
XTSX:RHC
|
CA |
Balance Sheet
Balance Sheet Decomposition
Milestone Pharmaceuticals Inc
Milestone Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Milestone Pharmaceuticals Inc
Milestone Pharmaceuticals Inc
Balance Sheet
Milestone Pharmaceuticals Inc
Milestone Pharmaceuticals Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
11
|
86
|
120
|
72
|
114
|
8
|
14
|
25
|
73
|
|
| Cash Equivalents |
11
|
86
|
120
|
72
|
114
|
8
|
14
|
25
|
73
|
|
| Short-Term Investments |
16
|
0
|
0
|
70
|
0
|
57
|
52
|
44
|
33
|
|
| Total Receivables |
1
|
1
|
1
|
1
|
1
|
1
|
4
|
2
|
4
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Current Assets |
0
|
1
|
2
|
5
|
4
|
6
|
3
|
2
|
2
|
|
| Total Current Assets |
28
|
88
|
123
|
149
|
119
|
72
|
73
|
74
|
112
|
|
| PP&E Net |
0
|
0
|
1
|
1
|
1
|
3
|
2
|
2
|
2
|
|
| PP&E Gross |
0
|
0
|
1
|
1
|
1
|
3
|
2
|
2
|
2
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
28
N/A
|
88
+219%
|
123
+40%
|
150
+22%
|
120
-20%
|
75
-38%
|
75
+1%
|
75
+0%
|
114
+50%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
1
|
3
|
4
|
5
|
4
|
2
|
4
|
2
|
6
|
|
| Accrued Liabilities |
1
|
2
|
4
|
2
|
2
|
4
|
3
|
6
|
8
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
5
|
8
|
6
|
7
|
6
|
7
|
8
|
14
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
50
|
53
|
57
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
1
|
|
| Total Liabilities |
2
N/A
|
5
+181%
|
9
+89%
|
7
-19%
|
7
+4%
|
8
+13%
|
58
+622%
|
62
+7%
|
72
+15%
|
|
| Equity | ||||||||||
| Common Stock |
60
|
141
|
226
|
252
|
252
|
274
|
261
|
288
|
353
|
|
| Retained Earnings |
35
|
58
|
114
|
116
|
153
|
232
|
278
|
314
|
375
|
|
| Additional Paid In Capital |
2
|
3
|
4
|
9
|
16
|
24
|
34
|
40
|
64
|
|
| Other Equity |
2
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
|
| Total Equity |
26
N/A
|
84
+221%
|
115
+38%
|
143
+25%
|
113
-21%
|
66
-41%
|
17
-75%
|
13
-22%
|
42
+218%
|
|
| Total Liabilities & Equity |
28
N/A
|
88
+219%
|
123
+40%
|
150
+22%
|
120
-20%
|
75
-38%
|
75
+1%
|
75
+0%
|
114
+50%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
24
|
24
|
25
|
30
|
30
|
34
|
33
|
53
|
106
|
|
Switch to:
Switch to:
See Also
Discover More
